0,981  0,002  Chemoprotective
0,971  0,001  Antimutagenic
0,942  0,002  Chemopreventive
0,940  0,002  Caspase 9 stimulant
0,928  0,002  NOS2 expression inhibitor
0,924  0,005  Alpha-glucosidase inhibitor
0,916  0,003  Antihypercholesterolemic
0,912  0,002  Monophenol monooxygenase inhibitor
0,899  0,001  Amylase inhibitor
0,900  0,002  UGT1A9 substrate
0,901  0,006  Transcription factor NF kappa B inhibitor
0,893  0,003  Genotoxic
0,891  0,002  Proliferative diseases treatment
0,892  0,004  TNF expression inhibitor
0,887  0,003  Vasodilator, coronary
0,865  0,003  Antihypoxic
0,864  0,004  Antioxidant
0,856  0,002  Melanin inhibitor
0,856  0,004  Cytostatic
0,852  0,002  Sulfotransferase substrate
0,847  0,004  Cardioprotectant
0,841  0,002  Xanthine oxidase inhibitor
0,837  0,002  Mediator release inhibitor
0,826  0,002  UGT1A1 substrate
0,827  0,005  Mutagenic
0,827  0,013  Apoptosis agonist
0,806  0,004  Free radical scavenger
0,810  0,014  Antiinflammatory
0,794  0,007  Antidiabetic
0,794  0,007  Cyclophilin D inhibitor
0,780  0,002  Carbonic anhydrase XIII inhibitor
0,772  0,009  CYP2C9 substrate
0,769  0,011  Teratogen
0,754  0,008  Radioprotector
0,739  0,004  Angiogenesis stimulant
0,735  0,005  NOS3 expression inhibitor
0,732  0,010  Carcinogenic
0,719  0,005  DNA damaging
0,717  0,005  Hypoglycemic
0,723  0,013  Embryotoxic
0,715  0,006  5 Hydroxytryptamine release stimulant
0,712  0,004  Histamine release inhibitor
0,703  0,002  Beta glucuronidase inhibitor
0,702  0,008  Antibacterial
0,694  0,005  Tumour necrosis factor alpha release inhibitor
0,705  0,018  CYP3A4 substrate
0,690  0,005  UDP-glucuronosyltransferase substrate
0,680  0,006  AR expression inhibitor
0,683  0,015  Antileukemic
0,677  0,009  Antithrombotic
0,668  0,007  Caspase 3 stimulant
0,659  0,003  VCAM1 expression inhibitor
0,663  0,007  Nitric oxide antagonist
0,674  0,024  Antineoplastic (breast cancer)
0,646  0,002  Antihemorrhagic
0,644  0,005  Apoptosis antagonist
0,641  0,007  Antipruritic, allergic
0,637  0,004  Skin whitener
0,634  0,005  Vascular (periferal) disease treatment
0,636  0,008  Hepatic disorders treatment
0,632  0,007  UGT1A6 substrate
0,625  0,002  Protein kinase stimulant
0,624  0,003  Cystathionine beta-synthase inhibitor
0,625  0,004  Hepatoprotectant
0,622  0,003  UGT2B4 substrate
0,642  0,025  Antineoplastic (lung cancer)
0,626  0,010  Cytotoxic
0,628  0,015  Cholesterol antagonist
0,617  0,004  Cyclic AMP phosphodiesterase inhibitor
0,624  0,012  CYP2C19 substrate
0,617  0,011  Spasmolytic
0,609  0,005  Antineoplastic (osteosarcoma)
0,604  0,008  Antiamyloidogenic
0,606  0,010  Antiparasitic
0,594  0,003  Expectorant
0,589  0,004  Non-steroidal antiinflammatory agent
0,587  0,003  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,587  0,005  Antihypertriglyceridemic
0,604  0,023  Antineoplastic (colorectal cancer)
0,581  0,015  Antineoplastic (cervical cancer)
0,573  0,009  Amyloid beta aggregation inhibitor
0,567  0,004  Antitussive
0,563  0,007  RNA-directed DNA polymerase inhibitor
0,569  0,017  Sensitization
0,572  0,025  Antineoplastic (colon cancer)
0,562  0,017  5 Hydroxytryptamine release inhibitor
0,551  0,008  Antihelmintic
0,540  0,004  Alkylator
0,556  0,022  Respiratory analeptic
0,545  0,012  Antiprotozoal (Leishmania)
0,554  0,024  Prostate cancer treatment
0,532  0,007  ICAM1 expression inhibitor
0,527  0,004  Neurotrophic factor enhancer
0,533  0,012  Hypoxia-inducible factor 1 alpha inhibitor
0,516  0,005  Interferon gamma antagonist
0,515  0,005  NOS3 expression enhancer
0,535  0,025  Immunostimulant
0,513  0,005  Antihypotensive
0,519  0,010  Vasodilator
0,513  0,008  Antineoplastic (sarcoma)
0,507  0,014  Antipyretic
0,499  0,008  Radiosensitizer
0,506  0,021  Antifungal
0,505  0,021  Antineoplastic (pancreatic cancer)
0,497  0,014  DNA synthesis inhibitor
0,503  0,024  Antineoplastic (melanoma)
0,493  0,013  Antineoplastic (lymphoma)
0,481  0,005  Aldehyde dehydrogenase inhibitor
0,493  0,020  Antineoplastic (brain cancer)
0,481  0,008  Septic shock treatment
0,477  0,010  P-glycoprotein inhibitor
0,491  0,025  Ulceration
0,498  0,034  Immunosuppressant
0,492  0,028  Antineoplastic (ovarian cancer)
0,466  0,004  Aldose reductase substrate
0,463  0,007  Lipid peroxidase inhibitor
0,463  0,007  Platelet adhesion inhibitor
0,456  0,003  DNA repair enzyme inhibitor
0,460  0,008  Antineoplastic (squamous cell carcinoma)
0,455  0,005  UGT2B15 substrate
0,448  0,005  Hemostatic
0,445  0,005  Antifungal enhancer
0,439  0,004  AMP-activated protein kinase stimulant
0,450  0,015  Interleukin 2 agonist
0,461  0,027  Analeptic
0,441  0,008  Topoisomerase II inhibitor
0,437  0,009  DNA methylase inhibitor
0,444  0,016  Antineoplastic enhancer
0,448  0,024  Antineoplastic (non-small cell lung cancer)
0,439  0,019  Antidiabetic symptomatic
0,437  0,017  Antineoplastic (liver cancer)
0,415  0,008  DNA methyltransferase I inhibitor
0,447  0,041  Vasodilator, peripheral
0,413  0,009  Antiviral (Influenza)
0,405  0,003  Nitric-oxide synthase stimulant
0,420  0,018  Myocardial infarction treatment
0,442  0,042  Stroke treatment
0,398  0,005  Carcinogenic, group 1
0,405  0,014  Antiviral (Herpes)
0,424  0,035  CYP1A2 substrate
0,392  0,008  Antineoplastic (gastric cancer)
0,390  0,014  Antineoplastic (carcinoma)
0,378  0,005  Hexokinase inhibitor
0,379  0,006  Topoisomerase I inhibitor
0,406  0,035  Antineoplastic (glioma)
0,449  0,080  Antineoplastic (solid tumors)
0,372  0,004  Selectin antagonist
0,374  0,007  UDP-glucose 4-epimerase inhibitor
0,362  0,004  Choleretic
0,363  0,006  NADPH oxidase inhibitor
0,391  0,033  Antineoplastic (multiple myeloma)
0,394  0,041  Antiischemic
0,350  0,003  Antihelmintic (Trematoda)
0,370  0,026  Antineoplastic (small cell lung cancer)
0,348  0,007  Psychosexual dysfunction treatment
0,376  0,037  Antidiabetic (type 2)
0,338  0,005  Topoisomerase II alpha inhibitor
0,341  0,011  Antidote
0,335  0,007  Interleukin 4 antagonist
0,330  0,005  Carbonic anhydrase III inhibitor
0,392  0,071  Antiprotozoal
0,324  0,004  Mannose-6-phosphate isomerase inhibitor
0,351  0,036  Antineoplastic (glioblastoma multiforme)
0,395  0,085  Calcium channel L-type activator
0,322  0,014  Antiviral (Influenza A)
0,324  0,017  Peptidyltransferase inhibitor
0,350  0,043  CYP1A2 inhibitor
0,311  0,004  Antiviral (Influenza B)
0,309  0,005  Cyclooxygenase 3 inhibitor
0,310  0,012  Acute respiratory distress syndrome (ARDS) treatment
0,337  0,040  Antineoplastic (renal cancer)
0,331  0,035  Interleukin agonist
0,354  0,058  Immunomodulator
0,345  0,051  CTGF expression inhibitor
0,356  0,063  Bone diseases treatment
0,299  0,006  Carbonic anhydrase VI inhibitor
0,299  0,015  Interleukin 6 antagonist
0,302  0,018  Muscular dystrophy treatment
0,341  0,059  Antimycobacterial
0,286  0,004  Photosensitizer
0,290  0,010  Antineoplastic antibiotic
0,287  0,007  Dementia treatment
0,295  0,017  Alpha-N-acetylglucosaminidase inhibitor
0,333  0,055  Antiosteoporotic
0,290  0,014  Insulin secretagoues
0,284  0,007  Vascular dementia treatment
0,335  0,064  CYP2D6 substrate
0,276  0,005  Aldose reductase inhibitor
0,285  0,015  Glutathione S-transferase substrate
0,376  0,105  Antiarthritic
0,341  0,071  Antiallergic
0,273  0,005  Antiviral (Ebola)
0,276  0,009  ATPase inhibitor
0,274  0,007  NADH dehydrogenase inhibitor
0,273  0,013  Antiprotozoal (Coccidial)
0,301  0,043  Antineoplastic (lymphocytic leukemia)
0,283  0,027  Thrombolytic
0,293  0,045  Antiulcerative
0,269  0,026  UGT1A3 substrate
0,280  0,038  Anesthetic general
0,248  0,007  Mucolytic
0,257  0,019  Antidiarrheal
0,267  0,029  Antipruritic, non-allergic
0,283  0,054  Antineoplastic (bladder cancer)
0,231  0,005  Histone deacetylase stimulant
0,231  0,005  Histone deacetylase SIRT1 stimulant
0,266  0,043  Sedative
0,239  0,017  Gout treatment
0,258  0,039  UGT2B7 substrate
0,220  0,008  Chronic obstructive bronchitis treatment
0,294  0,084  Antineoplastic (endocrine cancer)
0,228  0,021  SULT1A3 substrate
0,223  0,017  Antibacterial (Helicobacter pylori)
0,209  0,005  Heat shock protein 70 antagonist
0,209  0,008  Thioredoxin inhibitor
0,222  0,022  Cell wall synthesis inhibitor
0,205  0,009  Multidrug resistance-associated protein 1 inhibitor
0,202  0,006  Toll-Like receptor 4 antagonist
0,334  0,138  Alzheimer's disease treatment
0,207  0,013  Antineoplastic, alkylator
0,198  0,005  Phosphodiesterase 6D inhibitor
0,252  0,059  Antimitotic
0,197  0,004  Antibiotic Glycopeptide-like
0,209  0,017  CF transmembrane conductance regulator agonist
0,200  0,010  Sphingomyelinase inhibitor
0,198  0,010  Carcinogenic, group 2A
0,196  0,009  Transcription factor NF kappa B stimulant
0,199  0,013  Antibiotic
0,226  0,040  Antihelmintic (Nematodes)
0,197  0,013  Gastritis treatment
0,195  0,011  Antineoplastic (uterine cancer)
0,202  0,019  Antifungal (Cryptococcus)
0,194  0,011  Triose-phosphate isomerase inhibitor
0,203  0,025  DNA intercalator
0,208  0,030  Alkaline phosphatase inhibitor
0,227  0,050  Insulin sensitizer
0,210  0,034  Tubulin antagonist
0,301  0,125  CYP2C19 inhibitor
0,259  0,086  Lipoprotein disorders treatment
0,177  0,005  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,212  0,041  Liver fibrosis treatment
0,219  0,049  Sepsis treatment
0,185  0,015  Uric acid excretion stimulant
0,197  0,029  DNA polymerase I inhibitor
0,181  0,013  Phosphofructokinase-1 inhibitor
0,202  0,036  Antirickettsial
0,169  0,005  Carbonic anhydrase XIV inhibitor
0,230  0,068  Antiviral (HIV)
0,171  0,008  Interleukin 12 antagonist
0,205  0,045  Protein-tyrosine phosphatase inhibitor
0,176  0,017  Antispirochetal
0,162  0,005  Phosphodiesterase VI inhibitor
0,186  0,031  Antiviral (Hepatitis B)
0,209  0,053  Antiviral (Hepatitis)
0,181  0,029  Retinoprotector
0,183  0,032  Toll-Like receptor 2 antagonist
0,179  0,028  Chelator
0,181  0,031  Cell adhesion inhibitor
0,150  0,002  Sodium/glucose cotransporter inhibitor
0,212  0,065  Wound healing agent
0,190  0,045  UGT2B10 substrate
0,228  0,083  Platelet antagonist
0,203  0,059  Dual specificity phosphatase 3 inhibitor
0,190  0,049  Antineoplastic (bone cancer)
0,218  0,082  Cardiodepressant
0,136  0,002  Sodium/glucose cotransporter 2 inhibitor
0,164  0,029  SULT1A1 substrate
0,139  0,004  Alpha-mannosidase inhibitor
0,143  0,009  Antiviral (Dengue virus)
0,141  0,008  Na+ K+ transporting ATPase inhibitor
0,140  0,007  Carbonic anhydrase VII inhibitor
0,175  0,042  Acetylcholinesterase inhibitor
0,136  0,005  Antimycoplasmal
0,189  0,061  Tumour necrosis factor antagonist
0,131  0,006  Topoisomerase II beta inhibitor
0,248  0,124  Angiogenesis inhibitor
0,137  0,015  CDC25A inhibitor
0,163  0,041  Protein-tyrosine phosphatase 1B inhibitor
0,131  0,010  Neuraminidase (influenza) inhibitor
0,124  0,004  Mannosidase inhibitor
0,237  0,118  GST M1-1 substrate
0,178  0,059  Restenosis treatment
0,201  0,083  Interleukin antagonist
0,133  0,017  Interleukin 5 antagonist
0,162  0,045  Adenylate cyclase stimulant
0,143  0,027  Antifungal (Pneumocystis)
0,147  0,032  Anticataract
0,142  0,027  Estrogen antagonist
0,197  0,083  Pyruvate kinase inhibitor
0,128  0,014  Interferon agonist
0,218  0,104  Antiprotozoal (Trypanosoma)
0,126  0,013  Estrogen agonist
0,144  0,032  UGT2B1 substrate
0,114  0,002  Sodium/glucose cotransporter 1 inhibitor
0,150  0,038  Vanilloid 1 agonist
0,135  0,024  NAD(P)H dehydrogenase (quinone) inhibitor
0,182  0,072  Diabetic nephropathy treatment
0,220  0,111  Antituberculosic
0,135  0,026  Alcohol dehydrogenase inhibitor
0,119  0,011  Xanthine dehydrogenase inhibitor
0,126  0,018  HIV-1 integrase (3'-Processing) inhibitor
0,115  0,007  Fatty acid synthase inhibitor
0,176  0,070  Dual specificity phosphatase inhibitor
0,123  0,016  HIV-1 integrase (Strand Transfer) inhibitor
0,176  0,070  UGT1A4 substrate
0,123  0,018  ATPase (Vacuolar H+) inhibitor
0,105  0,004  Heparanase inhibitor
0,125  0,026  SULT1E1 substrate
0,110  0,012  Neuraminidase inhibitor
0,116  0,018  Thioredoxin reductase inhibitor
0,107  0,011  Protein 50S ribosomal subunit inhibitor
0,200  0,105  Aldehyde oxidase inhibitor
0,142  0,047  Beta amyloid protein antagonist
0,139  0,044  Carcinogenic, group 2B
0,112  0,017  T cell inhibitor
0,129  0,037  Electron transport complex I inhibitor
0,126  0,035  Breast cancer-resistant protein inhibitor
0,107  0,016  Postmenopausal disorders treatment
0,093  0,003  Antibiotic Aminoglycoside-like
0,122  0,033  UGT2B11 substrate
0,134  0,048  Microtubule formation inhibitor
0,207  0,120  Huntington's disease treatment
0,127  0,041  Bronchodilator
0,093  0,007  Glucose-6-phosphate translocase inhibitor
0,237  0,152  Antiprotozoal (Plasmodium)
0,090  0,006  Glucose-6-phosphate isomerase inhibitor
0,190  0,108  Aryl hydrocarbon receptor agonist
0,142  0,059  Carcinogenic, group 3
0,096  0,014  Interferon inducer
0,186  0,105  Hypolipemic
0,085  0,003  Cholesterol absorption inhibitor
0,148  0,070  Hair growth stimulant
0,177  0,099  VEGF expression inhibitor
0,095  0,019  Antitreponemal
0,080  0,004  Protein 30S ribosomal subunit inhibitor
0,095  0,021  Carbonic anhydrase XII inhibitor
0,090  0,017  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,108  0,035  Restless leg syndrome treatment
0,109  0,040  Arylamine N-Acetyltransferase substrate
0,085  0,018  Nitric oxide donor
0,110  0,046  Estrogen receptor beta antagonist
0,068  0,005  Nucleoside transporters inhibitor
0,111  0,048  Creatine kinase inhibitor
0,070  0,007  Neuraminidase (Influenza A) inhibitor
0,146  0,091  Uterine stimulant
0,096  0,042  Antiviral (Trachoma)
0,121  0,067  Growth stimulant
0,110  0,058  MAO A inhibitor
0,062  0,010  Arginase inhibitor
0,100  0,049  Antiviral (Rhinovirus)
0,065  0,014  Equilibrative nucleoside transport protein inhibitor
0,091  0,042  Glycine receptor antagonist
0,087  0,038  Narcotic antagonist
0,096  0,048  Glutamate release inhibitor
0,062  0,016  Factor III inhibitor
0,132  0,086  Cyclooxygenase inhibitor
0,100  0,054  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,095  0,051  Aminoacyl-tRNA synthetase inhibitor
0,083  0,039  Lipase inhibitor
0,081  0,037  HIV-1 integrase inhibitor
0,121  0,079  Cyclooxygenase 1 inhibitor
0,105  0,063  HDL-cholesterol increasing
0,064  0,023  Phosphorylase inhibitor
0,140  0,102  Cystic fibrosis treatment
0,165  0,127  Antialcoholic
0,067  0,030  Protein kinase C eta inhibitor
0,119  0,083  Papain-like protease (SARS coronavirus) inhibitor
0,117  0,082  Antihyperlipoproteinemic
0,071  0,037  CDC25B inhibitor
0,122  0,091  Neurotrophic factor
0,130  0,099  Eye irritation, high
0,115  0,086  Antiacne
0,031  0,003  Antibiotic Anthracycline-like
0,035  0,007  Toll-Like receptor 4 agonist
0,114  0,087  Cyclooxygenase 2 inhibitor
0,106  0,079  Adenylate cyclase inhibitor
0,032  0,008  Vanilloid 2 agonist
0,136  0,112  Antiviral (Hepatitis C)
0,130  0,106  Neuropathy treatment
0,132  0,108  Ca2+-transporting ATPase inhibitor
0,125  0,103  Antidiabetic (type 1)
0,052  0,029  Antiviral (Herpesvirus 3, Human)
0,042  0,020  Estrogen receptor alpha agonist
0,055  0,034  Alpha tubulin antagonist
0,143  0,122  Phospholipase C inhibitor
0,025  0,004  Telomerase stimulant
0,056  0,036  Adenine nucleotide translocase inhibitor
0,181  0,162  Lipoxygenase inhibitor
0,027  0,010  GRP78 expression inhibitor
0,048  0,033  Adenosine deaminase inhibitor
0,094  0,080  Antiprotozoal (Toxoplasma)
0,059  0,045  Antidote, heavy metal
0,126  0,112  Antinephritic
0,025  0,012  Dopamine D1 agonist
0,109  0,096  Bone formation stimulant
0,029  0,017  1,3-Beta-glucan synthase inhibitor
0,056  0,045  Lipocortins synthesis agonist
0,079  0,068  Ornithine decarboxylase inhibitor
0,025  0,016  Adenosine A1 receptor agonist
0,031  0,025  Estrogen-related receptor beta antagonist
0,031  0,025  Melatonin 2 agonist
0,030  0,024  Estrogen receptor beta agonist
0,017  0,012  Ileal bile acid transport inhibitor
0,026  0,021  Uridine phosphorylase inhibitor
0,093  0,090  Interleukin 1b antagonist
0,046  0,042  Cytokine production stimulant
0,121  0,118  UGT2B9 substrate
0,010  0,008  Purinergic P2Y2 agonist
0,047  0,046  Maillard reaction inhibitor
0,067  0,067  GABA aminotransferase inhibitor

